Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing ConsortiumFrank Dieterle, J. Eric McDuffie, Josef Ozer et al.|Nature Biotechnology|2010Cited by 406
The risks associated with short-term placebo-controlled antihypertensive clinical trials: a descriptive meta-analysisAlbert DeFelice, Raymond J. Lipicky, James Willard et al.|Journal of Human Hypertension|2008Cited by 23